12:00 AM
 | 
Apr 29, 2013
 |  BC Week In Review  |  Company News  |  Other News

Roche diagnostics news

Roche will dissolve its Roche Applied Science business and integrate the unit's product portfolio into its other diagnostics business areas by year end. The PCR technology and nucleic acid product lines of Applied Science will become part of Roche Molecular Diagnostics, while Applied Science's portfolio of platforms and reagents will be moved to Roche Professional Diagnostics. Roche said the changes...

Read the full 278 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >